Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier

Developmental Cell

Volumn 34, Issue 1, 2015, Pages 19-32

  Reyahi, Azadeh ^a   Nik, Ali M ^a   Ghiami, Mozhgan ^a   Gritli Linde, Amel ^b   Pontén, Fredrik ^c   Johansson, Bengt R ^a   Carlsson, Peter ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA8 INTEGRIN; FORKHEAD TRANSCRIPTION FACTOR; RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR FOXF2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; FOXF2 PROTEIN, HUMAN; FOXF2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN HEMORRHAGE; BRAIN PERICYTE; CAVEOLA; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EDEMA; EMBRYO; ENDOTHELIUM CELL; GENE DOSAGE; GENE EXPRESSION; HYPERPLASIA; MOUSE; NEURAL CREST CELL; NONHUMAN; PERIVASCULAR EDEMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; CYTOLOGY; METABOLISM; PERICYTE; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; MICE; PERICYTES; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84942420319     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2015.05.008     Document Type: Article

References (57)

1. Akamine R., Yamamoto T., Watanabe M., Yamazaki N., Kataoka M., Ishikawa M., Ooie T., Baba Y., Shinohara Y. Usefulness of the 5' region of the cDNA encoding acidic ribosomal phosphoprotein P0 conserved among rats, mice, and humans as a standard probe for gene expression analysis in different tissues and animal species. J. Biochem. Biophys. Methods 2007, 70:481-486.
2. Anderson K.D., Pan L., Yang X.M., Hughes V.C., Walls J.R., Dominguez M.G., Simmons M.V., Burfeind P., Xue Y., Wei Y., et al. Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. Proc. Natl. Acad. Sci. U S A 2011, 108:2807-2812.
3. Angerer L.M., Angerer R.C. In situ hybridization to cellular RNA with radiolabelled RNA probes. In Situ Hybridization: A Practical Approach 1992, 15-32. Oxford University Press, Oxford. D.G. Wilkinson (Ed.).
4. Armulik A., Genové G., Mäe M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., et al. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
5. Armulik A., Genové G., Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 2011, 21:193-215.
6. Arnold T.D., Niaudet C., Pang M.F., Siegenthaler J., Gaengel K., Jung B., Ferrero G.M., Mukouyama Y.S., Fuxe J., Akhurst R., et al. Excessive vascular sprouting underlies cerebral hemorrhage in mice lacking αVβ8-TGFβ signaling in the brain. Development 2014, 141:4489-4499.
7. Astorga J., Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development 2007, 134:3753-3761.
8. Bader B.L., Rayburn H., Crowley D., Hynes R.O. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998, 95:507-519.
9. Blixt A., Landgren H., Johansson B.R., Carlsson P. Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev. Biol. 2007, 302:218-229.
10. Cambier S., Gline S., Mu D., Collins R., Araya J., Dolganov G., Einheber S., Boudreau N., Nishimura S.L. Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am. J. Pathol. 2005, 166:1883-1894.
11. Cellini E., Disciglio V., Novara F., Barkovich J.A., Mencarelli M.A., Hayek J., Renieri A., Zuffardi O., Guerrini R. Periventricular heterotopia with white matter abnormalities associated with 6p25 deletion. Am. J. Med. Genet. A. 2012, 158A:1793-1797.
12. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
13. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
14. Etchevers H.C., Vincent C., Le Douarin N.M., Couly G.F. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001, 128:1059-1068.
15. Foster K., Sheridan J., Veiga-Fernandes H., Roderick K., Pachnis V., Adams R., Blackburn C., Kioussis D., Coles M. Contribution of neural crest-derived cells in the embryonic and adult thymus. J. Immunol. 2008, 180:3183-3189.
16. French C.R., Seshadri S., Destefano A.L., Fornage M., Arnold C.R., Gage P.J., Skarie J.M., Dobyns W.B., Millen K.J., Liu T., et al. Mutation of FOXC1 and PITX2 induces cerebral small-vessel disease. J. Clin. Invest. 2014, 124:4877-4881.
17. Gaengel K., Genové G., Armulik A., Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:630-638.
18. Goumans M.-J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002, 21:1743-1753.
19. Goumans M.J., Valdimarsdottir G., Itoh S., Lebrin F., Larsson J., Mummery C., Karlsson S., ten Dijke P. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol. Cell 2003, 12:817-828.
20. Hawkins B.T., Egleton R.D. Fluorescence imaging of blood-brain barrier disruption. J. Neurosci. Methods 2006, 151:262-267.
21. Hayashi S., McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 2002, 244:305-318.
22. Heglind M., Cederberg A., Aquino J., Lucas G., Ernfors P., Enerbäck S. Lack of the central nervous system- and neural crest-expressed forkhead gene Foxs1 affects motor function and body weight. Mol. Cell. Biol. 2005, 25:5616-5625.
23. Hellström M., Kalén M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999, 126:3047-3055.
24. Hirschi K.K., Burt J.M., Hirschi K.D., Dai C. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ. Res. 2003, 93:429-437.
25. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual 1994, Cold Spring Harbor Laboratory Press, New York. Second Edition.
26. Iwata J., Hacia J.G., Suzuki A., Sanchez-Lara P.A., Urata M., Chai Y. Modulation of noncanonical TGF-β signaling prevents cleft palate in Tgfbr2 mutant mice. J. Clin. Invest. 2012, 122:873-885.
27. Jakobsen J.S., Braun M., Astorga J., Gustafson E.H., Sandmann T., Karzynski M., Carlsson P., Furlong E.E.M. Temporal ChIP-on-chip reveals Biniou as a universal regulator of the visceral muscle transcriptional network. Genes Dev. 2007, 21:2448-2460.
28. Kapoor S., Mukherjee S.B., Shroff D., Arora R. Dysmyelination of the cerebral white matter with microdeletion at 6p25. Indian Pediatr. 2011, 48:727-729.
29. Karnovsky M.J. The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J. Cell Biol. 1967, 35:213-236.
30. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
31. Korn J., Christ B., Kurz H. Neuroectodermal origin of brain pericytes and vascular smooth muscle cells. J. Comp. Neurol. 2002, 442:78-88.
32. Kurz H. Cell lineages and early patterns of embryonic CNS vascularization. Cell Adh. Migr. 2009, 3:205-210.
33. Landgren H., Carlsson P. FoxJ3, a novel mammalian forkhead gene expressed in neuroectoderm, neural crest, and myotome. Dev. Dyn. 2004, 231:396-401.
34. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994, 8:1875-1887.
35. Li F., Lan Y., Wang Y., Wang J., Yang G., Meng F., Han H., Meng A., Wang Y., Yang X. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev. Cell 2011, 20:291-302.
36. Lindahl P., Johansson B.R., Levéen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242-245.
37. Mahlapuu M., Enerbäck S., Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development 2001, 128:2397-2406.
38. Mahlapuu M., Ormestad M., Enerbäck S., Carlsson P. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development 2001, 128:155-166.
39. Muzumdar M.D., Tasic B., Miyamichi K., Li L., Luo L. A global double-fluorescent Cre reporter mouse. Genesis 2007, 45:593-605.
40. Nik A.M., Reyahi A., Pontén F., Carlsson P. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling. Gastroenterology 2013, 144:1001-1011.
41. Ormestad M., Astorga J., Carlsson P. Differences in the embryonic expression patterns of mouse Foxf1 and -2 match their distinct mutant phenotypes. Dev. Dyn. 2004, 229:328-333.
42. Ormestad M., Astorga J., Landgren H., Wang T., Johansson B.R., Miura N., Carlsson P. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006, 133:833-843.
43. Pontén F., Jirström K., Uhlen M. The Human Protein Atlas-a tool for pathology. J. Pathol. 2008, 216:387-393.
44. Rosenberg R.E., Egan M., Rodgers S., Harter D., Burnside R.D., Milla S., Pappas J. Complex chromosome rearrangement of 6p25.3- > p23 and 12q24.32- > qter in a child with moyamoya. Pediatrics 2013, 131:e1996-e2001.
45. Sato Y., Rifkin D.B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 1989, 109:309-315.
46. Shi M., Zhu J., Wang R., Chen X., Mi L., Walz T., Springer T.A. Latent TGF-β structure and activation. Nature 2011, 474:343-349.
47. Siegenthaler J.A., Choe Y., Patterson K.P., Hsieh I., Li D., Jaminet S.C., Daneman R., Kume T., Huang E.J., Pleasure S.J. Foxc1 is required by pericytes during fetal brain angiogenesis. Biol. Open 2013, 2:647-659.
48. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994, 8:1888-1896.
49. Su E.J., Fredriksson L., Geyer M., Folestad E., Cale J., Andrae J., Gao Y., Pietras K., Mann K., Yepes M., et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 2008, 14:731-737.
50. van der Knaap M.S., Kriek M., Overweg-Plandsoen W.C., Hansson K.B., Madan K., Starreveld J.S., Schotman-Schram P., Barkhof F., Lesnik Oberstein S.A. Cerebral white matter abnormalities in 6p25 deletion syndrome. AJNR Am. J. Neuroradiol. 2006, 27:586-588.
51. Vernon H.J., Bytyci Telegrafi A., Batista D., Owegi M., Leigh R. 6p25 microdeletion: white matter abnormalities in an adult patient. Am. J. Med. Genet. A. 2013, 161A:1686-1689.
52. Wang T., Tamakoshi T., Uezato T., Shu F., Kanzaki-Kato N., Fu Y., Koseki H., Yoshida N., Sugiyama T., Miura N. Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate. Dev. Biol. 2003, 259:83-94.
53. Winkler E.A., Bell R.D., Zlokovic B.V. Central nervous system pericytes in health and disease. Nat. Neurosci. 2011, 14:1398-1405.
54. Wipff P.-J., Hinz B. Integrins and the activation of latent transforming growth factor β1 - an intimate relationship. Eur. J. Cell Biol. 2008, 87:601-615.
55. Yamanishi E., Takahashi M., Saga Y., Osumi N. Penetration and differentiation of cephalic neural crest-derived cells in the developing mouse telencephalon. Dev. Growth Differ. 2012, 54:785-800.
56. Zhu J., Motejlek K., Wang D., Zang K., Schmidt A., Reichardt L.F. beta8 integrins are required for vascular morphogenesis in mouse embryos. Development 2002, 129:2891-2903.
57. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.